Revolution Medicines, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Revolution Medicines, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Revolution Medicines, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $600K, a 14.3% decline year-over-year.
  • Revolution Medicines, Inc. Operating Lease, Payments for the twelve months ending March 31, 2023 was $2.3M.
  • Revolution Medicines, Inc. annual Operating Lease, Payments for 2022 was $2.4M, a 60% increase from 2021.
  • Revolution Medicines, Inc. annual Operating Lease, Payments for 2021 was $1.5M, a 42.3% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $2.3M $600K -$100K -14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.4M $500K Oct 1, 2022 Dec 31, 2022 10-K 2023-02-27
Q3 2022 $200K -$500K -71.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1M Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $700K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q3 2021 $700K +$100K +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q1 2021 $2.5M $700K -$100K -12.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $2.6M $700K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $600K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $500K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $800K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.